Aardvark Labs Aardvark Labs Capital Research Reports Tickers Models Calendar About & Disclosures 中文日本語한국어

← All companies

Elevance Health, Inc.

Elevance Health (ELV)

Outperform Current rating · 4 reports

2026-04-23

Outperform Recap: Q1 2026

Maintaining Outperform: A Nonrecurring-Heavy Beat-and-Raise — But the Recovery Got Confirmed AND De-Risked, With the Medicaid Trough Holding and the 2027 MA Rate Firming, Against a Contained $935M CMS Overhang

2026-01-29

Outperform Recap: Q4 2025

Upgrading to Outperform: The Trough Is Finally a Number — $25.50 for 2026, a −1.75% Medicaid Bottom, and an Explicit ≥12% Snap-Back in 2027 Off a Washed-Out ~13x Base

2025-10-22

Hold Recap: Q3 2025

Maintaining Hold: The Reset Held and the Third Cut Didn't Come — But a $1-of-Below-the-Line "Beat" and a 2026 Management Calls "the Trough" Mean the Recovery Still Can't Be Underwritten

2025-07-18

Hold Recap: Q2 2025

Initiating at Hold: A Second Straight In-Year Cut Resets FY25 to ~$30, and Management Won't Touch 2026 — Visibility Is Too Poor to Catch a Knife Down 34% in a Year

About & Disclosures

© 2026 Aardvark Labs Capital Research. All rights reserved.